Partnership Will Help Uptake of Specialist Diagnostics

Arquer Diagnostics has appointed Alpha Laboratories as its exclusive distributor in the UK and Republic of Ireland. Sunderland-based Arquer develops breakthrough diagnostic tests for the detection of bladder and prostate cancer. Its non-invasive cancer diagnostic tests are based on the MCM5 (minichromosome maintenance protein) platform. The first Arquer product is ADXBLADDER, a bladder cancer diagnostic test and a number of clinical trials are running to validate many other indications.

Michelle Holland, Alpha Laboratories’ Diagnostics Sales and Marketing director says, “Arquer shares the Alpha Laboratories’ vision to provide innovative diagnostic pathways that enhance patient care and improve outcomes, whilst reducing overall healthcare costs. We welcome this partnership to expand our specialist diagnostics portfolio into this important clinical area.”

“One of the key elements of the success of any product launch is the quality of the technical and scientific support delivered to all stakeholders. I am extremely excited about the partnership with Alpha Laboratories, as they have an incredible track record of success and a reputation in the IVD field. The Arquer Diagnostics’ Team and I look forward to many years of success together with Alpha Laboratories”, says Nadia Whittley, Arquer CEO.